Potenza Therapeutics - Ownership and Business Overview

Life ScienceCompany

Potenza Therapeutics Ownership

Who owns Potenza Therapeutics?

Potenza Therapeutics is owned by Astellas Pharma. It was acquired on December 14, 2018.

Potenza Therapeutics Business Overview

Where is Potenza Therapeutics headquartered?

Potenza Therapeutics is headquartered in Cambridge, Massachusetts.

What sector is Potenza Therapeutics in?

Potenza Therapeutics is a life science company.

When was Potenza Therapeutics founded?

Potenza Therapeutics was founded in 2014.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

Potenza Therapeutics, Inc.

1030 Massachusetts Ave., Suite 210,
Cambridge, Massachusetts 02138
United States,
(617) 588-4150
www.potenzatherapeutics.com

Potenza Therapeutics, Inc. is a portfolio of oncology programs that utilize the body's own immune system to seek out, recognize and destroy tumors. Potenza Therapeutics was founded in 2014 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.